Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.
Umbralisib led to remission in 49% of patients with marginal zone lymphoma and 43% of those with follicular lymphoma.
Here’s a list of the approved drugs to treat lyphoma including Non-Hodgkin lymphoma and Hodgkin lymphoma. Click on any of the medicat...
In a new website post, he provided an update on his treatment, thoughts on the U.S. and a new song.
Those with blood cancers are nine times more likely to be hospitalized or die from the flu.
The checkpoint inhibitor is approved for adults and children with relapsed lymphoma.
A dedicated student of jiujitsu, Avie Barron, 36, was diagnosed with non-Hodgkin lymphoma in her right lung.
Here are latest arrivals approved by the Food and Drug Administration.
The agency also announced the qualification of a tool to aid in the effectiveness assessment of devices used in breast reconstruction.
Lymphoma is a cancer that begins in the cells of the lymph system.
World Lymphoma Awareness Day (WLAD) is held on September 15 every year and is a day dedicated to raising awareness of lymphoma.
More than a third of people treated with Monjuvi plus Revlimid experienced complete remission.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.